Ambuja Cements (AMBUJACEM) — deviation variation

Ambuja Cements Limited confirms zero deviation in fund utilization for Q1 FY2026. The company raised ₹15,000.046 crores through preferential warrant conversion across two tranches (March and April 2024) for capital expenditure, de-bottlenecking, logistics infrastructure, ESG compliance, acquisitions, and working capital. As of June 30, 2025, ₹14,385.1 crores has been deployed aligned with original stated purposes, with no variances reported or flagged by the Audit Committee.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AMBUJACEM ✨ Ask AI About This

About Ambuja Cements Limited (AMBUJACEM)

Construction Materials · Cement & Cement Products · Listed on NSE

Market Cap: ₹1,07,215.34 Cr P/E: 23.3 ROE: 7.7% ROCE: 4.6%

View full AMBUJACEM stock details →

📡 Get AI alerts when AMBUJACEM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AMBUJACEM — Free

💡 Ask AI about this filing

"How does this deviation variation affect Ambuja Cements Limited's outlook?" "What did Ambuja Cements Limited announce on 31 July 2025?" "Is this positive or negative for AMBUJACEM?"

Ask AI Free →

📊 More AMBUJACEM filings

See all AMBUJACEM filings →

🔥 Also filed on 31 July 2025

SUNPHARMA Sun Pharmaceutical Industries Limited Financial Results RELIANCE Reliance Industries Limited Corporate Action SBICARD SBI Cards and Payment Services Limited Annual Report SRF SRF Limited Financial Results SBILIFE SBI Life Insurance Company Limited Financial Results TATASTEEL Tata Steel Limited Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AMBUJACEM files new disclosures

Track AMBUJACEM filings, board meetings, and corporate actions. Free email alerts at 5 PM.